HERG ½ºÅ©¸®´× ½ÃÀå : À¯Çüº°, ÀÌ¿Âä³Îº°, °Ë»ç¹ýº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, ±¹°¡º°, Áö¿ªº° - »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, ½ÃÀå Á¡À¯À², ¿¹Ãø(2024-2032³â)
HERG Screening Market, By Type, By Ion Channel, By Testing Methods, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
»óǰÄÚµå : 1485738
¸®¼­Ä¡»ç : AnalystView Market Insights
¹ßÇàÀÏ : 2024³â 05¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 287 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,250 £Ü 4,511,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 4,650 £Ü 6,455,000
PDF (5 User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,650 £Ü 7,843,000
PDF & Excel (Enterprise User License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» ¸ðµç »ç¿ëÀÚ°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¸®Æ÷Æ® ÇÏÀ̶óÀÌÆ®

HERG ½ºÅ©¸®´× ½ÃÀå ±Ô¸ð´Â 2023³â¿¡ 11¾ï 2,445¸¸ ´Þ·¯¿¡ ´ÞÇϸç, 2024-2032³â CAGR 10.9%·Î È®´ë

HERG ½ºÅ©¸®´× ½ÃÀå - ½ÃÀå ¿ªÇÐ

¾àÁ¦ Çõ½ÅÀÇ Áõ°¡¿Í ½ÉÇ÷°üÁúȯÀÇ À¯º´·üÀÌ ½ÃÀå ¼ºÀåÀ» ÃËÁø

HERG ½ºÅ©¸®´× ½ÃÀåÀº ¾à¹° Çõ½Å Áõ°¡¿Í ½ÉÇ÷°ü ÁúȯÀÇ À¯º´·ü Áõ°¡·Î ÀÎÇØ °­·ÂÇÑ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î ¼¼°èº¸°Ç±â±¸(WHO)¿¡ µû¸£¸é ½ÉÇ÷°ü ÁúȯÀº ¿©ÀüÈ÷ ¼¼°è ÁÖ¿ä »ç¸Á ¿øÀÎÀ¸·Î ¿¬°£ 1,790¸¸ ¸íÀÌ »ç¸ÁÇÏ´Â °ÍÀ¸·Î Ãß»êµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¹Ì±¹ ½ÄǰÀǾ౹(FDA)Àº ºÎÀÛ¿ëÀ» ÁÙÀ̱â À§ÇØ ÀǾàǰ °³¹ß Áß ½ÉÀå ¾ÈÀü¼º Æò°¡ÀÇ Á߿伺À» °­Á¶Çϸç HERG ½ºÅ©¸®´×ÀÇ Áß¿äÇÑ ¿ªÇÒÀ» °­Á¶Çϰí ÀÖ½À´Ï´Ù. Á¦¾àȸ»çµéÀÌ ½Å¾à ¹× Ä¡·á¹ý °³¹ß¿¡ ÁýÁßÇϸ鼭 ½ÉÇ÷°ü Áúȯ¿¡ ´ëÇÑ º¸´Ù ¾ÈÀüÇϰí È¿°úÀûÀÎ Ä¡·á¹ýÀ» È®º¸Çϱâ À§ÇØ HERG ½ºÅ©¸®´× ¼­ºñ½º¿¡ ´ëÇÑ ¼ö¿ä´Â Áö¼ÓÀûÀ¸·Î Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

HERG ½ºÅ©¸®´× ½ÃÀå - ÁÖ¿ä ÀλçÀÌÆ®

´ç»çÀÇ ¸®¼­Ä¡ ºÐ¼®°¡µéÀÇ ºÐ¼®¿¡ µû¸£¸é ¼¼°è ½ÃÀåÀº ¿¹Ãø ±â°£(2024-2032) µ¿¾È ¿¬Æò±Õ ¾à 10.9%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î ¸Å³â ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

À¯Çü ¼¼ºÐÈ­¿¡ µû¶ó KCNH2 À¯ÀüÀÚ´Â 2023³â °¡Àå Å« ½ÃÀå Á¡À¯À²À» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµÇ¾ú½À´Ï´Ù.

À̿ ä³Î ¼¼ºÐÈ­¿¡ µû¸£¸é 2023³â ÀüÀ§ ÀÇÁ¸¼º À̿ ä³ÎÀÌ ÁÖ¿ä À¯ÇüÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù.

°Ë»ç ¹æ¹ýº°·Î´Â ÀÚµ¿ Àü±â»ý¸® ½Ã½ºÅÛÀÌ 2023³â ÁÖ¿ä À¯ÇüÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù.

¿ëµµº°·Î º¸¸é 2023³â¿¡´Â Ç׺ÎÁ¤¸ÆÁ¦°¡ ÁÖ¿ä À¯ÇüÀ̾ú½À´Ï´Ù.

ÃÖÁ¾»ç¿ëÀÚº°·Î´Â Á¦¾àȸ»ç°¡ 2023³â ÁÖ¿ä À¯ÇüÀ̾ú½À´Ï´Ù.

Áö¿ªº°·Î´Â ºÏ¹Ì°¡ 2023³â ¸ÅÃâ¿¡¼­ ¼±µÎ¸¦ Â÷ÁöÇß½À´Ï´Ù.

HERG ½ºÅ©¸®´× ½ÃÀå - ¼¼ºÐÈ­ ºÐ¼® :

¼¼°è HERG ½ºÅ©¸®´× ½ÃÀåÀº À¯Çü, À̿ ä³Î, °Ë»ç ¹æ¹ý, ¾ÖÇø®ÄÉÀ̼Ç, ÃÖÁ¾»ç¿ëÀÚ ¹× Áö¿ª¿¡ µû¶ó ¼¼ºÐÈ­µË´Ï´Ù.

½ÃÀåÀº À¯Çü¿¡ µû¶ó À¯ÀüÀÚ KCNH2¿Í º¯ÀÌÇü KCNH2ÀÇ µÎ °¡Áö ¹üÁÖ·Î ³ª´¹´Ï´Ù. À¯ÀüÀÚ KCNH2´Â Á¤»óÀûÀÎ ½ÉÀå ±â´É ¹× ¾à¹° »óÈ£ ÀÛ¿ë Æò°¡¿Í °ü·ÃÀÌ ÀÖÀ¸¹Ç·Î ¸Å¿ì ¼±È£µË´Ï´Ù. º¯ÀÌÇü KCNH2´Â Ç¥Àû ¿¬±¸ ¹× ¾à¹° ¹ÝÀÀ Æò°¡¸¦ À§ÇØ Æ¯Á¤ º¯ÀÌÇü¿¡ ÃÊÁ¡À» ¸ÂÃá ÀÌÂ÷Àû ÀÎ °ÍÀÔ´Ï´Ù.

½ÃÀåÀº À̿ ä³Î¿¡ µû¶ó ÀüÀ§ ÀÇÁ¸¼º À̿ ä³Î, ¸®°£µå ÀÇÁ¸¼º À̿ ä³Î, ±â°è ¹Î°¨¼º À̿ ä³Î, ÀϽÃÀû ¼ö¿ëü ÀüÀ§ µî ³× °¡Áö ¹üÁÖ·Î ³ª´¹´Ï´Ù. ÀüÀ§ ÀÇÁ¸¼º À̿ ä³ÎÀº ½ÉÀå ±â´É ¹× ¾à¹° À¯¹ß ºÎÁ¤¸Æ¿¡¼­ Áß½ÉÀûÀÎ ¿ªÇÒÀ»Çϱ⠶§¹®¿¡ ¸Å¿ì ¼±È£µË´Ï´Ù. ¸®°£µå ÀÇÁ¸¼º À̿ ä³ÎÀº ƯÁ¤ ¾à¹° »óÈ£ ÀÛ¿ë¿¡¼­ Áß¿äÇÕ´Ï´Ù. ±â°è ¹Î°¨¼º ä³Î°ú ÀϽÃÀû ¼ö¿ëü ÀüÀ§ ä³ÎÀº ½ÉÀå ¾ÈÀü¼º Æò°¡¿¡¼­ ´ú ¼±È£µË´Ï´Ù.

HERG ½ºÅ©¸®´× ½ÃÀå - Áö¿ªÀû ÀλçÀÌÆ®

ºÏ¹ÌÁö¿ªÀº źźÇÑ Á¦¾à»ê¾÷ÀÌ Á¸ÀçÇϰí, ½ÉÀå ¾ÈÀü¿¡ ´ëÇÑ ¾ö°ÝÇÑ ±ÔÁ¦±âÁØÀ¸·Î ÀÎÇØ ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ Áö¿ªÀº ¶ÇÇÑ ¿¬±¸°³¹ß, ƯÈ÷ Çõ½ÅÀû ½Å¾à°³¹ß¿¡ ¸¹Àº ÅõÀÚ¸¦ Çϰí ÀÖ´Â °ÍÀÌ Æ¯Â¡ÀÔ´Ï´Ù. À¯·´Àº À¯»çÇÑ ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©¿Í Á¤¹ÐÀÇ·á¿¡ ´ëÇÑ ÁýÁßÀûÀÎ ³ë·ÂÀ¸·Î ±× µÚ¸¦ ÀÕ°í ÀÖ½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº ÀÇ·áºñ ÁöÃâ Áõ°¡, Á¦¾à ºÎ¹® È®´ë, ÀǾàǰ ¾ÈÀü¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ ºü¸¥ ¼ºÀå ÀáÀç·ÂÀ» º¸¿©ÁÖ°í ÀÖ½À´Ï´Ù. Áß±¹, Àεµ µî ½ÅÈï ±¹°¡Àº ÀÇ·á ÀÎÇÁ¶óÀÇ ¹ßÀü°ú »õ·Î¿î Ä¡·áÁ¦¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ÈûÀÔ¾î HERG ½ºÅ©¸®´× ±â¼ú äÅÃÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Áö¿ªº° ÀλçÀÌÆ®´Â HERG ½ºÅ©¸®´× ½ÃÀåÀÇ ¼¼°è È®»ê°ú ÁøÈ­ÇÏ´Â »óȲÀ» Áö¿øÇÕ´Ï´Ù.

HERG ½ºÅ©¸®´× ½ÃÀå - °æÀï ±¸µµ:

Charles River Laboratories International Inc., Cyprotex PLC, Eurofins Scientific, Cerep SA¿Í °°Àº ÁÖ¿ä ±â¾÷Àº Á¾ÇÕÀûÀÎ HERG ½ºÅ©¸®´× ¼­ºñ½º¸¦ Á¦°øÇÏ´Â À¯¸íÇÑ ±â¾÷ÀÔ´Ï´Ù. ÀÌµé ±â¾÷Àº ÀÚµ¿ ÆÐÄ¡ Ŭ·¥ÇÎ, ÇÏÀ̽º·çDz ½ºÅ©¸®´×°ú °°Àº ÷´Ü ±â¼úÀ» Ȱ¿ëÇÏ¿© ½ÉÀå ¾ÈÀü¼º Æò°¡ÀÇ È¿À²¼º°ú Á¤È®¼ºÀ» ³ôÀÌ´Â µ¥ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. Á¦¾à ´ë±â¾÷°úÀÇ Àü·«Àû Á¦ÈÞ ¹× Çù·Â °ü°è¸¦ ÅëÇØ ½ÃÀå ¹üÀ§¸¦ ³ÐÈ÷°í ¸ÂÃãÇü ¼Ö·ç¼ÇÀ» Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ Nanion Technologies¿Í Sophion Bioscience¿Í °°Àº ½Å»ý ±â¾÷Àº ´Ù¾çÇÑ ÀǾàǰ °³¹ß ¿ä±¸¿¡ ºÎÀÀÇÏ´Â »õ·Î¿î HERG ½ºÅ©¸®´× Ç÷§ÆûÀ¸·Î Àα⸦ ²ø°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ HERG ½ºÅ©¸®´× ½ÃÀå¿¡¼­ ÁÖ¸ñÇÒ ¸¸ÇÑ Çù¾÷ »ç·Ê·Î´Â Charles River Laboratories International Inc.¿Í AstraZenecaÀÇ Á¦ÈÞ¸¦ µé ¼ö ÀÖ½À´Ï´Ù. ÀÌ Á¦ÈÞ´Â HERG ½ºÅ©¸®´× ºÐ¼®À» Æ÷ÇÔÇÑ »õ·Î¿î ½ÉÀå ¾ÈÀü¼º Å×½ºÆ® ÆÐ³ÎÀÇ °³¹ß ¹× °ËÁõÀ» ÅëÇØ ½Å¾à °³¹ß ¹× ¾à¹° °³¹ß ³ë·ÂÀ» Áö¿øÇÏ´Â °ÍÀ» ¸ñÇ¥·Î Çϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå HERG ½ºÅ©¸®´× ½ÃÀå °³¿ä

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå HERG ½ºÅ©¸®´×ÀÇ ÁÖ¿ä ½ÃÀå µ¿Çâ

Á¦4Àå HERG ½ºÅ©¸®´× ¾÷°è Á¶»ç

Á¦5Àå HERG ½ºÅ©¸®´× ½ÃÀå : COVID-19ÀÇ ¿µÇ⠺м®

Á¦6Àå HERG ½ºÅ©¸®´× ½ÃÀå ±¸µµ

Á¦7Àå HERG ½ºÅ©¸®´× ½ÃÀå : À¯Çüº°

Á¦8Àå HERG ½ºÅ©¸®´× ½ÃÀå : ÀÌ¿Âä³Îº°

Á¦9Àå HERG ½ºÅ©¸®´× ½ÃÀå : °Ë»ç¹ýº°

Á¦10Àå HERG ½ºÅ©¸®´× ½ÃÀå : ¿ëµµº°

Á¦11Àå HERG ½ºÅ©¸®´× ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

Á¦12Àå HERG ½ºÅ©¸®´× ½ÃÀå : Áö¿ªº°

Á¦13Àå ÁÖ¿ä º¥´õ ºÐ¼® - HERG ½ºÅ©¸®´× ¾÷°è

Á¦14Àå ¾Ö³Î¸®½ºÆ®ÀÇ Àü¹æÀ§ Àü¸Á

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

REPORT HIGHLIGHT

HERG Screening Market size was valued at USD 1,124.45 million in 2023, expanding at a CAGR of 10.9% from 2024 to 2032.

The HERG screening market, vital in drug development to assess compounds for cardiac safety, is driven by stringent drug safety regulations necessitating early cardiac risk identification, alongside a rising incidence of cardiac disorders globally. Advancements in drug discovery technologies and precision medicine further bolster demand for sophisticated HERG screening methods. However, challenges such as high equipment costs, data complexity, and ethical concerns around animal models restrict market growth. Opportunities lie in untapped emerging markets, continuous technological advancements enhancing screening efficiency, strategic collaborations between pharmaceutical entities, and screening providers driving innovation in HERG screening tailored for specific therapeutic areas.

HERG Screening Market- Market Dynamics

Rising Drug Innovation and Cardiovascular Disease Prevalence Driving the Market Growth

The HERG screening market is experiencing robust growth driven by increasing drug innovation and the rising prevalence of cardiovascular diseases. For instance, according to the World Health Organization (WHO), cardiovascular diseases remain the leading cause of death globally, with an estimated 17.9 million deaths annually. Additionally, the U.S. Food and Drug Administration (FDA) emphasizes the importance of cardiac safety assessments during drug development to mitigate adverse effects, highlighting the critical role of HERG screening. With pharmaceutical companies focusing on developing novel drugs and therapies, the demand for HERG screening services continues to escalate, ensuring safer and more effective treatments for cardiovascular conditions.

HERG Screening Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 10.9% over the forecast period (2024-2032)

Based on Type segmentation, Gene KCNH2 was predicted to show maximum market share in the year 2023

Based on Ion Channel segmentation, voltage-gated ion channel was the leading type in 2023

Based on Testing Methods segmentation, Automated Electrophysiology Systems was the leading type in 2023

Based on Application segmentation, Antiarrhythmic was the leading type in 2023

Based on end-user segmentation, Pharmaceutical Companies were the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

HERG Screening Market- Segmentation Analysis:

The Global HERG Screening Market is segmented based on Type, ION Channel, Testing Methods, Application, End User, and Region.

The market is divided into two categories based on Type: Gene KCNH2 and mutant KCNH2. gene KCNH2 is highly preferred due to its relevance in assessing normal cardiac function and drug interactions. Mutant KCNH2 is secondary preferred, focusing on specific variants for targeted studies and drug response evaluations.

The market is divided into four categories based on ION Channel: Voltage-Gated Ion Channel, Ligand-Gated Ion Channel, Mechanosensitive, and Transient receptor potential. Voltage-gated ion channels are highly preferred due to their central role in cardiac function and drug-induced arrhythmia. Ligand-gated ion channels follow, important for specific drug interactions. Mechanosensitive and transient receptor potential channels are less commonly prioritized for cardiac safety assessments.

HERG Screening Market- Geographical Insights

North America dominates the market due to the presence of a well-established pharmaceutical industry and stringent regulatory standards emphasizing cardiac safety. The region is also characterized by substantial investments in research and development, particularly in innovative drug discovery. Europe follows closely, driven by similar regulatory frameworks and a significant focus on precision medicine. Asia Pacific showcases rapid growth potential attributed to increasing healthcare expenditure, expanding pharmaceutical sector, and rising awareness about drug safety. Emerging economies in this region, such as China and India, are witnessing growing adoption of HERG screening technologies fueled by advancements in healthcare infrastructure and a burgeoning demand for novel therapeutics. These geographical insights underscore the global reach and evolving landscape of the HERG screening market.

HERG Screening Market- Competitive Landscape:

Key companies such as Charles River Laboratories International Inc., Cyprotex PLC, Eurofins Scientific, and Cerep SA are prominent players offering comprehensive HERG screening services. These companies focus on leveraging advanced technologies like automated patch clamping and high-throughput screening to enhance efficiency and accuracy in cardiac safety assessments. Strategic partnerships and collaborations with pharmaceutical giants enable them to broaden their market reach and offer tailored solutions. Additionally, emerging players like Nanion Technologies and Sophion Bioscience are gaining traction with novel HERG screening platforms catering to diverse drug development needs. Furthermore, one notable instance of collaboration in the HERG screening market is the partnership between Charles River Laboratories International Inc. and AstraZeneca. This collaboration aimed to develop and validate a new cardiac safety testing panel, including HERG screening assays, to support drug discovery and development efforts.

Recent Developments:

In August 2023, Metrion Biosciences Limited was accepted into the UK GLP Compliance Monitoring Programme by the Medicines and Healthcare Products Regulatory Agency (MHRA). This allows the company to provide GLP-compliant hERG ion channel screening services worldwide.

In March 2020, Charles River Laboratories and Deciphex have partnered to co-develop deep learning-enabled pathology analytics. Charles River will exclusively offer Deciphex's Patholytix preclinical solution.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL HERG SCREENING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Aurora Biomed Inc.

Axion Biosystems

Cerep SA (a part of Eurofins Scientific)

Charles River Laboratories International, Inc.

Confluence Discovery Technologies

Cyprotex (a division of Evotec SE)

Cytocentrics AG

Eurofins Discovery

Icagen, Inc. (a division of Domain Therapeutics)

Metrion Biosciences Ltd.

MilliporeSigma (Merck KGaA)

Nanion Technologies GmbH

Ncardia

PerkinElmer, Inc.

SB Drug Discovery

Sophion Bioscience A/S

Others

GLOBAL HERG SCREENING MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

GLOBAL HERG SCREENING MARKET, BY ION CHANNEL- MARKET ANALYSIS, 2019 - 2032

GLOBAL HERG SCREENING MARKET, BY TESTING METHODS- MARKET ANALYSIS, 2019 - 2032

GLOBAL HERG SCREENING MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

GLOBAL HERG SCREENING MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

GLOBAL HERG SCREENING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

Table of Contents

1.HERG Screening Market Overview

2.Executive Summary

3.HERG Screening Key Market Trends

4.HERG Screening Industry Study

5.HERG Screening Market: COVID-19 Impact Analysis

6.HERG Screening Market Landscape

7.HERG Screening Market - By Type

8.HERG Screening Market - By Ion Channel

9.HERG Screening Market - By Testing Methods

10.HERG Screening Market - By Application

11.HERG Screening Market - By End User

12.HERG Screening Market- By Geography

13.Key Vendor Analysis- HERG Screening Industry

14.360 Degree Analyst View

15.Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â